Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Plasma cell 1Myeloid 1

Conditions

Multiple Myeloma 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, Non-Hodgkin 10Lymphoma, Mantle-Cell 10Lymphoma, Large-Cell, Immunoblastic 10Lymphoma, Large B-Cell, Diffuse 10Lymphoma, Follicular 10Lymphoma, B-Cell, Marginal Zone 10Leukemia, Lymphocytic, Chronic, B-Cell 10Hodgkin Disease 10Burkitt Lymphoma 10Leukemia, Myeloid, Chronic-Phase 9Leukemia, Myeloid, Acute 9Leukemia, Myeloid, Accelerated Phase 8Leukemia, Hairy Cell 8Blast Crisis 8Myeloproliferative Disorders 7Lymphoma, T-Cell, Cutaneous 7Leukemia, Myelomonocytic, Chronic 7Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 7Primary Myelofibrosis 6Neoplasms 6Testicular Neoplasms 5Sezary Syndrome 5Pdgfra-Associated Chronic Eosinophilic Leukemia 5Mycosis Fungoides 5Leukemia, Neutrophilic, Chronic 5Congenital Abnormalities 5Carcinoma, Ovarian Epithelial 5Breast Neoplasms 5

Interventions

Cyclophosphamide 2fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Therapeutics 1Peripheral Blood Stem Cell Transplantation 1Mesna 1Melphalan 1Influenza Vaccines 1Honey 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Immunologic Deficiency Syndromes × Therapeutics × Plasma cell × Clear all
NCT05655546 2025-08-08

ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

Scripps Translational Science Institute

Phase NA Terminated
2,117 enrolled 6 charts
LymphoidOther hematologic neoplasmPlasma cell

COVID-19, Graft vs Host Disease, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Multiple Myeloma, Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡